The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain

被引:642
作者
Elia, AEH
Rellos, P
Haire, LF
Chao, JW
Ivins, FJ
Hoepker, K
Mohammad, D
Cantley, LC
Smerdon, SJ [1 ]
Yaffe, MB
机构
[1] Natl Inst Med Res, Div Prot Struct, London NW7 1AA, England
[2] MIT, Ctr Canc Res, Dept Biol, Cambridge, MA 02139 USA
[3] Harvard Univ, Beth Israel Deaconess Hosp, Sch Med, Dept Cell Biol,Div Signal Transduct, Boston, MA 02215 USA
关键词
D O I
10.1016/S0092-8674(03)00725-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Polo-like kinases (Plks) perform crucial functions in cell-cycle progression and multiple stages of mitosis. Plks are characterized by a C-terminal noncatalytic region containing two tandem Polo boxes, termed the Polo-box domain (PBD), which has recently been implicated in phosphodependent substrate targeting. We show that the PBDs of human, Xenopus, and yeast Plks all recognize similar phosphoserine/threonine-containing motifs. The 1.9 Angstrom X-ray structure of a human Plk1 PBD-phosphopeptide complex shows that the Polo boxes each comprise beta(6)alpha structures that associate to form a 12-stranded beta sandwich domain. The phosphopeptide binds along a conserved, positively charged cleft located at the edge of the Polo-box interface. Mutations that specifically disrupt phosphodependent interactions abolish cell-cycle-dependent localization and provide compelling phenotypic evidence that PBD-phospholigand binding is necessary for proper mitotic progression. In addition, phosphopeptide binding to the PBD stimulates kinase activity in full-length Plk1, suggesting a conformational switching mechanism for Plk regulation and a dual functionality for the PBD.
引用
收藏
页码:83 / 95
页数:13
相关论文
共 50 条
[1]  
Abrieu A, 1998, J CELL SCI, V111, P1751
[2]   Mammalian Polo-like kinase 3 (PIU) is a multifunctional protein involved in stress response pathways [J].
Bahassi, EM ;
Conn, CW ;
Myer, DL ;
Hennigan, RF ;
McGowan, CH ;
Sanchez, Y ;
Stambrook, PJ .
ONCOGENE, 2002, 21 (43) :6633-6640
[3]   RIBBONS 2 0 [J].
CARSON, M .
JOURNAL OF APPLIED CRYSTALLOGRAPHY, 1991, 24 :958-&
[4]  
Conn CW, 2000, CANCER RES, V60, P6826
[5]   The polo-like kinase Plx1 is required for M phase exit and destruction of mitotic regulators in Xenopus egg extracts [J].
Descombes, P ;
Nigg, EA .
EMBO JOURNAL, 1998, 17 (05) :1328-1335
[6]   The molecular basis of FHA Domain:Phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms [J].
Durocher, D ;
Taylor, IA ;
Sarbassova, D ;
Haire, LF ;
Westcott, SL ;
Jackson, SP ;
Smerdon, SJ ;
Yaffe, MB .
MOLECULAR CELL, 2000, 6 (05) :1169-1182
[7]   Polo-like kinase1, a new target for antisense tumor therapy [J].
Elez, R ;
Piiper, A ;
Giannini, CD ;
Brendel, M ;
Zeuzem, S .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (02) :352-356
[8]   Proteomic screen finds pSer/pThr-binding domain localizing Plk1 to mitotic substrates [J].
Elia, AEH ;
Cantley, LC ;
Yaffe, MB .
SCIENCE, 2003, 299 (5610) :1228-1231
[9]   Polo-like kinases: a team that plays throughout mitosis [J].
Glover, DM ;
Hagan, IM ;
Tavares, AAM .
GENES & DEVELOPMENT, 1998, 12 (24) :3777-3787
[10]   The cyclin-ubiquitin ligase activity of cyclosome/APC is jointly activated by protein kinases Cdk1-cyclin B and Plk [J].
Golan, A ;
Yudkovsky, Y ;
Hershko, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (18) :15552-15557